Research

rs2304795 — PLIN1

Synonymous exon 8 variant in perilipin 1 that tags a haplotype associated with fat mobilization efficiency and sex-specific obesity risk

Moderate Risk Factor Share

Details

Gene
PLIN1
Chromosome
15
Risk allele
G
Consequence
Synonymous
Inheritance
Additive
Clinical
Risk Factor
Evidence
Moderate
Chip coverage
v3 v4 v5

Population Frequency

AA
39%
AG
47%
GG
14%

Ancestry Frequencies

south_asian
52%
african
38%
european
37%
latino
34%
east_asian
28%

See your personal result for PLIN1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

The Perilipin Gatekeeper: How rs2304795 Shapes Fat Mobilization

Perilipin 1 (PLIN1) is the most abundant protein coating lipid droplets11 most abundant protein coating lipid droplets
Lipid droplets are the cellular fat-storage organelles inside adipocytes, each wrapped in a protein shell that controls access to the stored triglycerides
in fat cells. Think of it as a bouncer at the door to your fat stores — in the unfed state, perilipin keeps lipases locked out, preventing uncontrolled fat breakdown. When energy is needed and hormones signal via PKA phosphorylation22 PKA phosphorylation
Protein kinase A phosphorylates perilipin at multiple serine residues, triggering a conformational change that exposes stored triglycerides to lipases
, perilipin opens the door for hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL)33 hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL)
The two key enzymes that sequentially break down stored triglycerides into free fatty acids during fat mobilization
to break down stored fat. Common variants at the PLIN1 locus subtly alter this gatekeeping function, influencing how readily adipose tissue releases fat under caloric stress.

rs2304795 (13041A>G) is a synonymous variant in exon 8 — it does not change the amino acid sequence at position 371 (proline remains proline). Nevertheless, it has been consistently implicated in obesity risk and fat mobilization across multiple populations, most likely because it serves as a marker for a linked functional variant44 marker for a linked functional variant
Synonymous variants can tag haplotypes carrying nearby causal variants, or can themselves affect mRNA structure, splicing efficiency, or translational rate
elsewhere in the PLIN1 haplotype block.

The Mechanism

The G allele tags a haplotype that appears to confer stronger perilipin-mediated protection of lipid droplets. Under this model, fat cells with G-allele haplotypes are more resistant to lipolytic signals — stored triglycerides remain sequestered for longer during energy deficit. This has two opposing consequences: in the context of chronic positive energy balance, stronger fat retention elevates obesity risk; in conditions of extreme catabolism (severe illness, cancer treatment), it offers partial protection against uncontrolled fat mass loss.

The molecular basis likely involves expression-level changes in PLIN1 isoforms or altered mRNA structure affecting translation efficiency, though direct functional characterization of this specific synonymous change has not been published. The strong sex-specificity of associations — effects are predominantly observed in women — is consistent with perilipin's known interactions with estrogen-regulated lipolytic signaling55 estrogen-regulated lipolytic signaling
Estrogens modulate beta-adrenergic receptor density and PKA responsiveness in adipose tissue, creating sex-specific sensitivity to perilipin variants
.

The Evidence

The foundational study by Qi et al. 200466 Qi et al. 2004
n=734 white US adults (373 men, 361 women); first systematic analysis of PLIN1 haplotype and obesity
identified rs2304795 and rs1052700 as obesity-associated, with minor G alleles linked to increased obesity risk in women. Associations with percentage body fat and waist circumference were significant in women but not men. A complementary gender-specific haplotype study77 gender-specific haplotype study
n=1,065 white European adults; sex-stratified analysis
confirmed that haplotypes carrying the 13041G allele conferred approximately 1.7-fold increased obesity risk in women, again without significant effects in men.

In an endurance exercise intervention88 endurance exercise intervention
6-month supervised training in 101 older Caucasians (mean age 63)
, the major AA haplotype (carriers of the common A allele at both rs2304795 and rs1052700) was associated with lower baseline BMI, lower body fat, and lower intra-abdominal fat compared to non-carriers before and after training. The PLIN haplotype explained approximately 2.5% of variance in body composition phenotypes.

The most striking data on rs2304795 comes from an oncology cohort99 oncology cohort
80 head and neck cancer patients (60 men, 20 women) undergoing radiotherapy; Polish population
. AA genotype men lost 37.01% of their fat mass during treatment versus 12.82% in GA carriers and only 0.31% in GG carriers (p = 0.035). In multivariate analysis, the AA genotype carried an OR of 13.78 for ≥10% fat mass loss (p = 0.032). This extreme effect — a genotype explaining a 100-fold difference in fat loss magnitude — is unusual in genetics and likely reflects acute metabolic stress amplifying a normally subtle regulatory difference. Nonetheless, it illustrates the functional range of this variant: the G allele strongly protects fat from mobilization even under duress.

Evidence for dietary weight loss interventions is more modest. In a 12-week caloric restriction study1010 12-week caloric restriction study
Energy restriction to -300 kcal/day; 4.6% mean weight loss
, rs2304795 haplotype influenced serum free fatty acid levels and abdominal fat responses. An 8-week energy restriction study1111 8-week energy restriction study
Obese Spanish women, -500 kcal/day
found no interaction between the 13041A>G variant and diet-induced changes in body fat or energy metabolism independently, suggesting its effects may require haplotype context (i.e., co-occurring with rs1052700).

Overall evidence level is moderate: consistent replication across populations for obesity risk associations, a clear biological framework, but no randomized controlled trials and no clinical guidelines. Effect sizes are modest for obesity risk (OR ~1.7 in women) but large and highly specific in metabolic stress conditions.

Practical Implications

For individuals carrying one or two G alleles, the key insight is that their adipose tissue is more resistant to lipolytic signals. This does not mean fat loss is impossible — caloric deficit still drives weight loss — but it may be slower to initiate and more dependent on sustained caloric restriction rather than short-term interventions. Two approaches are specifically relevant to this genotype:

First, dietary protein distribution matters because higher protein intake stimulates glucagon and catecholamines that amplify beta-adrenergic lipolytic signaling, helping overcome perilipin's protective function. Second, carbohydrate restriction reduces insulin, which normally suppresses HSL activity; lower insulin levels allow perilipin phosphorylation to proceed more readily during energy deficit.

For AA homozygotes, the opposite concern applies: adipose tissue is more lipolytically sensitive, which is favorable for weight management but can become problematic during illness, aggressive dietary restriction, or other catabolic states where uncontrolled fat loss increases malnutrition risk.

Interactions

rs2304795 is most commonly studied as part of a haplotype with rs10527001212 rs1052700
The 14995A>T variant in the PLIN1 3′ region, in moderate LD with rs2304795 and with its own independent association with weight loss response
(14995A>T). The combined AA haplotype at both positions defines a "low-fat-retention" phenotype associated with lower baseline body fat and better responses to exercise. Individuals carrying the AG haplotype (AA at rs2304795, TT at rs1052700) occupy an intermediate position. The rs894160 and rs2289487 pair1313 rs894160 and rs2289487 pair
Strongly linked to each other in white populations; associated with protective effects against obesity in Spanish women but not US women, illustrating population-dependent LD patterns
represents a second, partially independent PLIN1 haplotype with its own obesity associations, underscoring the complexity of variation across this locus.

Supervisor note — candidate compound action: individuals carrying the G allele at rs2304795 AND the T allele at rs1052700 form the highest-fat-retention haplotype. Published evidence from the exercise intervention and haplotype obesity studies suggests this combination (AG or GG at rs2304795 with AT or TT at rs1052700) is associated with the highest obesity risk and poorest exercise-induced fat loss response among PLIN1 haplotypes. A combined recommendation to prioritize sustained caloric deficit with higher protein intake rather than relying on exercise for fat loss would be appropriate for this genotype combination.

Nutrient Interactions

dietary fat altered_metabolism
protein increased_need

Genotype Interpretations

What each possible genotype means for this variant:

AA “High Fat Mobility” Normal

Common genotype associated with normal to high lipolytic sensitivity in adipose tissue

The AA genotype represents the ancestral haplotype at the PLIN1 locus. Cross-population data from gnomAD show an A allele frequency of approximately 62%, making AA the most common single genotype. In exercise intervention studies, AA haplotype carriers showed significantly lower total body fat and intra-abdominal fat both before and after a 6-month endurance training program compared to G allele carriers, suggesting more efficient baseline fat mobilization. The most dramatic illustration of this genotype's higher lipolytic sensitivity came from an oncology study in which AA men undergoing radiotherapy lost 37% of their fat mass compared to 12% in AG carriers and virtually none in GG carriers — an extreme amplification of the same underlying biological difference under catabolic stress.

This does not mean AA individuals are immune to obesity — lifestyle, diet, and other genetic factors dominate adiposity outcomes. But when placed in caloric deficit, AA carriers tend to mobilize fat stores more readily than G allele carriers.

AG “Moderate Fat Retention” Intermediate Caution

One G allele moderately increases adipose resistance to lipolysis, with sex-specific obesity risk in women

Heterozygote AG carriers occupy an intermediate position in the PLIN1 lipolysis spectrum. In the head and neck cancer radiotherapy study, AG men lost 12.82% of their fat mass during treatment — intermediate between AA carriers (37%) and GG carriers (0.3%). In population studies, the AG haplotype is part of the set of PLIN1 variants that carry modestly elevated obesity odds ratios in women (approximately 1.3-1.7-fold in heterozygotes vs. the protective haplotype), though effect sizes at the individual SNP level are modest.

The sex specificity of PLIN1 effects is consistent with the known interaction between estrogens and adipose lipolysis. Women have higher perilipin expression in certain fat depots and different beta-adrenergic receptor densities compared to men, creating a hormonal context where PLIN1 genetic variation has measurable phenotypic consequences. The AG genotype in women may particularly affect lower-body (gluteofemoral) fat stores, which are more perilipin-dense than abdominal fat.

GG “High Fat Retention” High Risk Warning

Two G alleles confer the strongest perilipin-mediated protection of fat stores, with higher obesity risk and reduced fat mobilization during caloric deficit

The GG genotype represents the high-fat-retention end of the PLIN1 spectrum. In the most striking published dataset — a study of cancer patients undergoing radiotherapy — GG men lost only 0.31% of their fat mass during treatment compared to 12.82% in AG carriers and 37% in AA carriers, yielding an OR of 13.78 for ≥10% fat mass loss associated with the AA genotype (reference for GG). While this extreme catabolic context amplifies the effect, it illustrates a fundamental biological difference in lipolytic sensitivity.

In population studies, the GG genotype (as part of the G-allele haplotype) is associated with increased obesity risk in women (OR approximately 1.7-fold in some cohorts), higher body fat percentage, and greater waist circumference. The exercise intervention study found that G allele carriers maintained higher BMI and body fat throughout a 6-month endurance training program compared to AA carriers, suggesting that exercise alone is insufficient to normalize the lipolytic deficit. Short-term weight loss programs (3-month) showed GG genotype predicting ≥5% weight loss, but this benefit did not persist at 12 months, suggesting initial response may not translate to long-term success without dietary changes.

Mechanistically, the GG haplotype likely keeps more perilipin molecules in the unphosphorylated, lipid-droplet-protective state, requiring stronger or more sustained hormonal signals to initiate effective lipolysis. Reducing dietary carbohydrate lowers insulin (which normally inhibits HSL), and increasing protein elevates glucagon and catecholamines — both dietary strategies that work with the biology to overcome stronger perilipin protection.

Key References

PMID: 15355432

Qi et al. 2004 — PLIN rs2304795 and rs1052700 associated with increased obesity risk in US white women; significant for body fat % and waist circumference

PMID: 15601970

Corella et al. 2005 — gender-specific association of PLIN haplotype (13041A>G + 14995A>T) with obesity risk; haplotypes A/T and G/T raised obesity OR ~1.75 in women

PMID: 16585946

Mottagui-Tabar et al. 2006 — PLIN haplotypes influence serum free fatty acids and abdominal fat changes during 12-week caloric restriction

PMID: 18812483

Olivier et al. 2009 — PLIN rs2304795 (PLIN5) showed no significant association with metabolic syndrome or weight loss in obese children

PMID: 19385027

Vogels et al. 2009 — PLIN1 C-allele haplotype associated with lower body weight and fat mass in men; greater weight loss in women

PMID: 21392418

Milagro et al. 2011 — rs2304795 (13041A>G) showed no interaction with diet-induced changes during 8-week energy restriction in obese women

PMID: 33388935

Borowiec et al. 2021 — AA genotype of rs2304795 associated with dramatically greater fat mass loss during radiotherapy (37% vs 12% vs 0.3% for GG), OR 13.78 for ≥10% fat loss